Studien & Berichte
Whitepaper, Forschungsberichte und Marktdaten
Studien & Berichte
25. Aug. 2026•1 Min. Lesezeit
GLP‑1 Agonists Linked to Higher Hypotension Risk in Patients on Blood‑Pressure Meds
A Northwestern Medicine study found that adding GLP‑1 drugs such as semaglutide, tirzepatide or liraglutide to antihypertensive therapy increased incidents of dizziness, fainting and low‑blood‑pressure events.
Studien & Berichte
25. Aug. 2026•1 Min. Lesezeit
Ventoscity launches VENTOs wearable to measure gut hydrogen for data-driven gut health
Ventoscity's coin-sized VENTOs wearable, attached to underwear, measures intestinal hydrogen gas to objectively assess probiotic and prebiotic efficacy, marking a shift to data-driven gut health management.
Studien & Berichte
25. Aug. 2026•1 Min. Lesezeit
MHRA Calls for Contributions to Study Genetic Links to DOAC and Allopurinol Side Effects
The UK Medicines and Healthcare products Regulatory Agency invites participation in a Yellow Card Biobank study to examine genetic factors behind side effects of direct‑acting oral anticoagulants and allopurinol.
Studien & Berichte
25. Aug. 2026•1 Min. Lesezeit
Intermittent Fasting Cuts Stress‑Induced Depression, Protects Myelin
Japanese researchers found intermittent fasting reshapes gut microbiota and safeguards brain myelin, easing depression‑like behavior from chronic stress.
Studien & Berichte
25. Aug. 2026•1 Min. Lesezeit
Study Links Paternal Valproate Use at Conception to Neurodevelopmental Risks in Children
A study suggests valproate use by men near conception may be linked to higher risk of neurodevelopmental disorders in offspring.
1
Studien & Berichte
24. Aug. 2026•1 Min. Lesezeit
Migraine Affects Approximately 6.5% of Koreans, Predominantly Women
Migraine prevalence in Korea is estimated at 6.5%, with women three times more affected than men.
Studien & Berichte
24. Aug. 2026•1 Min. Lesezeit
Verastem Shifts R&D Focus After Modest Data on Pancreatic Cancer Combo
Verastem Oncology reports modest updated results for its approved first‑line metastatic pancreatic cancer regimen of avutometinib plus defactinib and will redirect primary R&D resources to other pipeline candidates.
Studien & Berichte
24. Aug. 2026•1 Min. Lesezeit
Novo targeted by hacking groups in multi‑million ransomware attempt
Two separate hacking rings accessed confidential Novo data and allegedly tried to extort the company for multi‑million‑dollar ransom payments.
Studien & Berichte
24. Aug. 2026•1 Min. Lesezeit
PMDA Workshop on New Approach Methodologies (NAMs) Held after ICCR‑20
The Pharmaceuticals and Medical Devices Agency (PMDA) held a workshop on New Approach Methodologies (NAMs) following the ICCR‑20 symposium.
1
Studien & Berichte
23. Aug. 2026•1 Min. Lesezeit
PMDA Concludes MoU with London School of Hygiene & Tropical Medicine
The Pharmaceuticals and Medical Devices Agency (PMDA) has signed a Memorandum of Understanding with the London School of Hygiene & Tropical Medicine to promote joint work in pharmaceutical research and regulatory science.
Studien & Berichte
23. Aug. 2026•1 Min. Lesezeit
PMDA Updates One-Stop Service Platform by ENSEMBLExJ
The Pharmaceuticals and Medical Devices Agency (PMDA) has refreshed the One-Stop Service Platform page for ENSEMBLExJ, providing updated information for stakeholders.
Studien & Berichte
23. Aug. 2026•1 Min. Lesezeit
Mirabegron Study for OAB Completed
Astellas Pharma's mirabegron study for overactive bladder in China is completed. The study evaluated efficacy and safety of mirabegron.
3
1